Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 16Terminated 7Active not recruiting 4Unknown 3Recruiting 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Recurrence 1Neuroblastoma 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Extranodal NK-T-Cell 1Hematologic Neoplasms 1Graft vs Host Disease 1

Interventions

Rituximab 3Cyclophosphamide 3zanubrutinib 2fludarabine 2tafasitamab 1resiniferatoxin 1obinutuzumab 1duvelisib 1Vincristine 1Vancomycin 1Thiotepa 1Surveys and Questionnaires 1Radiotherapy 1Prednisone 1Prednisolone 1PTH2 protein, human 1Observation 1Neuropsychological Tests 1Methotrexate 1Magnetic Resonance Spectroscopy 1Lisaftoclax 1Interleukin-2 1Injections, Subcutaneous 1Homoharringtonine 1Glucocorticoids 1Doxorubicin 1Dexamethasone 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Lymphoma, Non-Hodgkin × Thiotepa × Clear all
NCT06646211 2024-10-17

High-dose Methotrexate Combined with Thiotepa and Zanubrutinib in the Treatment of Newly Diagnosed PCNSL (MTZ)

Sun Yat-sen University

Phase 2 Not yet recruiting
30 enrolled
Lymphoid

Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡